Florida receives FDA approval to import drugs from Canada for the first time

Florida Gets FDA Approval: For the first time ever, a state was permitted to import specific prescription pharmaceuticals straight from Canada according to an approval from the Food and Drug Administration (FDA) on Friday. This move affects Florida specifically.

The pharmaceutical industry, which is expected to file a lawsuit, has fiercely opposed the decision, which represents a significant shift in U.S. drug policy.Because it cannot ensure their safety, the FDA has also expressed concerns about the safety of importing medications from outside the country.

While it is legal for individuals to purchase medications from Canadian pharmacies, states have long attempted to acquire cheaper medications directly from Canadian wholesalers.

Like in most other nations, Canada has lower prescription medicine prices because the government has direct price-negotiation power with pharmaceutical corporations.

Both Florida Governor Ron DeSantis, a Republican presidential contender, and President Joe Biden celebrate the approval as a political win. Drug price reduction has been a top priority for both Biden and DeSantis.

Oxychloroquine may have killed close to 17,000 individuals, according to a research.

Florida was the first state to apply when the Trump administration released regulations in 2020 permitting states to submit applications for medicine importation.An executive order signed by Biden in 2021 provided the idea fresh impetus and instructed federal agencies to collaborate with states on importation strategies.

The new financial law in Florida: Is the disclosure law helpful?

Florida Gets FDA Approval

DeSantis, however, sued the FDA for “reckless delay” in approving the request, citing the agency’s inactivity as the reason.

Florida claims that it will start by offering prescription prescriptions in a limited number of drug classifications, including treatments for those with long-term illnesses including mental illness, diabetes, COPD, asthma, and HIV/AIDS.

The imported medications would only be provided to state-run programmes including Medicaid, the jail system, and establishments under the Department of Children & Families.

A federal court rejected a lawsuit filed in 2020 by the industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA) and two other groups against the Trump administration over the importation initiative.

The organisation stated in a statement on Friday that it was “considering all options” to stop the regulation from taking effect.

“The FDA’s careless decision to approve Florida’s state importation proposal has us extremely concerned. It is imperative to guarantee that patients receive the necessary medications; yet, the importation of unapproved medications, from Canada or other countries, presents a significant risk to public health. President and CEO of PhRMA Stephen J. Ubl stated, “Politicians ought to quit standing in the way of Americans’ access to healthcare.

“PhRMA is exploring every avenue to ensure that patients are not harmed by this policy.”